Levofloxacin Prophylaxis in Newly Diagnosed Myeloma Patients

Mark T. Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire Hulme, Irene M. Monahan, Kamaraj Karunanithi, Helen Dignum, Edward Belsham, Jeff Neilson, Beth Harrison, Anand Lokare, Gavin Campbell, Michael R Hamblin, Peter M. Hawkey, Anna C. Whittaker, Eric Low, Janet Dunn

Article2024

Outcomes of Newly Diagnosed Multiple Myeloma Patients Requiring Dialysis

Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Maria Gavriatopoulou, Vasiliki Spiliopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Erasmia Psimenou, Nikolaos Kanellias, Μαρία Ρούσσου, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis

Article2011

Levofloxacin Prophylaxis in Newly Diagnosed Myeloma Patients

Discussion(0)

Related publications

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Outcomes of Newly Diagnosed Multiple Myeloma Patients Requiring Dialysis

Deletion 17p in Unselected Newly Diagnosed Symptomatic Patients with Multiple Myeloma

Zoledronic acid for all patients with newly diagnosed multiple myeloma?

Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease.